Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
Director, 10%+ Owner
-
Stock Symbol
-
BNTC on Nasdaq
Suvretta Capital Management, Llc - trading volume in the past year for Benitec Biopharma Inc.
Holdings reported by Suvretta Capital Management, Llc for Benitec Biopharma Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common stock, par value $0.0001 per share |
955K |
$9.17M |
$9.60 |
Dec 3, 2024 |
Indirect |
|
|
Common stock, par value $0.0001 per share |
221K |
$673K |
$3.04 |
Apr 22, 2024 |
I |
|
|
Pre-Funded Warrants |
428K |
|
|
Sep 26, 2024 |
Indirect |
Common Stock |
|
Common Warrants |
0 |
|
|
Sep 26, 2024 |
Indirect |
Common Stock |
|
Series 2 Common Warrants |
0 |
|
|
Sep 26, 2024 |
Indirect |
Common Stock |
|
Transactions reported by Suvretta Capital Management, Llc for Benitec Biopharma Inc.
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.